IFNA1 and hepatocellular carcinoma: Screening, surveillance of patients at risk in combination with vaccinations against HBV and treatment against the HCV, previously based on interferon (IFN), and now based on direct-acting antiviral drugs (DAA), have allowed an improvement in the management and survival of HCC cases, but not in the total eradication of this disease [4,5].